| Clinical study "common" name (formal title) | Number of enrollees (per protocol [PP]/intent-to-treat [ITT]) | Funding source (pharmaceutical company/National Institutes of Health [NIH]) | Year completed | Primary publication | Full study treatment protocol |
|---|---|---|---|---|---|
| Treatment of Polypoidal Choroidal Vasculopathy by Photodynamic Therapy, Aflibercept and Dexamethasone Triple Therapy | 13 patients, 17 eyes | N/A | 2015 |
Ho M, Woo DC, Chan VC, Young AL, Brelen ME. Treatment of polypoidal choroidal vasculopathy by photodynamic therapy, aflibercept and dexamethasone triple therapy. Sci Rep. 2016;6:36870.
https://www.nature.com/articles/srep36870 |
N/A |